1. Medtech Insight
  2. >>Policy & Regulation

Lawmakers Question Effectiveness Of Free Sample Reporting Requirements

 
• By Sue Darcey

The US House Energy and Commerce Committee’s health subpanel mostly heard arguments against a bill that would require device makers to report the value of free samples they give out to health care providers.

Doctor shows glucometer with glucose level. doctor patient diabetes glucometer blood glucose office hand concept

US lawmakers and health care experts questioned the idea of requiring device manufacturers to report the value of samples they give away to providers, at a 21 May congressional hearing on controlling drug prices and other health care costs.

A bill, H.R. 2064, introduced by Rep. Judy Chu, D-CA, would require makers of drugs, devices, biologics and medical supplies to report to the federal government on product samples provided...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.